Navigation Links
Poniard Pharmaceuticals Announces Upcoming Conference Participation
Date:5/1/2008

SOUTH SAN FRANCISCO, Calif., May 1 /PRNewswire-FirstCall/ -- Poniard Pharmaceuticals, Inc. (Nasdaq: PARD), a biopharmaceutical company focused on oncology, today announced that Jerry McMahon, Ph.D., chairman and CEO, will participate in two upcoming conferences in May:

-- The Leerink Swann "Conquering Cancer with Novel Therapeutics"

Roundtable Conference on May 9 at 1:35 p.m. Eastern Time at the Grand

Hyatt New York

-- The CitiGroup Health Care Conference on May 21 at 9:30 a.m. Eastern

Time at the New York Hilton

A live audio webcast of the presentation at CitiGroup will be available for 10 business days on the "Events" page of the "News & Events" section of the Company's website at http://www.poniard.com.

About Poniard Pharmaceuticals

Poniard Pharmaceuticals, Inc. is a biopharmaceutical company focused on the development and commercialization of innovative oncology products to impact the lives of people with cancer. Picoplatin, the Company's lead platform product candidate, is a new generation platinum therapy with an improved safety profile relative to existing platinum-based cancer therapies. Picoplatin is designed to overcome platinum resistance associated with chemotherapy in solid tumors, and is being studied in multiple cancer indications, combinations and formulations. Clinical trials of intravenous picoplatin include a Phase 3 trial in small cell lung cancer and Phase 2 trials in metastatic colorectal and hormone-refractory prostate cancers, as well as a Phase 1 clinical trial of oral picoplatin in solid tumors. Picoplatin has not been approved by any regulatory authority for use in humans. For additional inform
'/>"/>

SOURCE Poniard Pharmaceuticals, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2

Related biology technology :

1. Poniard Pharmaceuticals Announces Participation in Upcoming Conferences
2. Poniard Pharmaceuticals Announces Upgrade of Stock Listing to NASDAQ Global Market
3. Poniard Pharmaceuticals Announces European Commission Grants Orphan Medicinal Product Designation to Picoplatin for Treatment of Small Cell Lung Cancer
4. Poniard Pharmaceuticals Appoints Robert De Jager, M.D., as Chief Medical Officer
5. Vion Pharmaceuticals Pays Interest on 7.75% Convertible Senior Notes
6. China Biopharmaceuticals Holdings Announces Second Quarter 2007 Financial Results
7. Vion Pharmaceuticals Completes Accrual of 85 Patients to its Pivotal Phase II Trial of Cloretazine(R) (VNP40101M) in Elderly AML
8. XTL Biopharmaceuticals Announces Financial Results for the Six Months Ended June 30, 2007
9. Cadence Pharmaceuticals Reports Second Quarter 2007 Financial Results
10. Nabi Biopharmaceuticals to Present at Upcoming Industry Conferences
11. Anadys Pharmaceuticals Appoints Steve Worland, Ph.D. as President and Chief Executive Officer
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:10/30/2014)... Global polyvinyl chloride (PVC) demand registered a significant ... especially in North America and Europe. However, the global ... a growing trend. , The largest chunk of the ... segment. In 2013, the key PVC application spheres included ... film. Moreover, the PVC was consumed in the production ...
(Date:10/30/2014)... San Diego, CA (PRWEB) October 30, 2014 ... company announced today that they have manually curated public ... Pharma and non profit customers. the data is ... BioSciences manually curates and unifies public and internal data ... more value and knowledge out of the data that ...
(Date:10/30/2014)... Avure Technologies celebrates a year of success and the ... fleet of high volume High Pressure Processing (HPP) systems. , ... to PackExpo this year, which is where we first announced ... Williams, CEO at Avure. “Sales of the new Avure machine ... the challenges of market demand for higher throughput. We sold ...
(Date:10/30/2014)... 30, 2014  Regado Biosciences, Inc. (Nasdaq: ... conference call and live audio webcast on Thursday, November ... third quarter 2014 financial results. Interested participants ... (888) 347-1165 for domestic callers or (412) 902-4276 for ... under the investor relations section of the Regado website ...
Breaking Biology Technology:Global Polyvinyl Chloride Demand Is on Upward Trend Now, Says Merchant Research & Consulting in Its Topical Study 2Global Polyvinyl Chloride Demand Is on Upward Trend Now, Says Merchant Research & Consulting in Its Topical Study 3Rancho BioSciences Manually Curated TCGA Data Sets Available 2In High Demand: New High Pressure Processing (HPP) System with Maximum Throughput Drives Strong Sales 2In High Demand: New High Pressure Processing (HPP) System with Maximum Throughput Drives Strong Sales 3Regado Biosciences to Provide Third Quarter 2014 Financial Results 2
... aOva Technologies , a developer of natural egg protein ... , ,aOva recently announced the closing of its latest financing ... ahead of schedule. The funding, collected from various angel investors, ... of antibody egg products that improve feed efficiency and animal ...
... Madison, Wis. - Wisconsin's two largest cities ... throughout their geographic limits, and several others continue ... addition to localized wireless "hot-spots" offered in public ... Milwaukee, Waukesha, and Shawano continue to make strides ...
... about work life isn't. Everyone knows the present organization ... to translate this into actual practice, despite this having ... , ,This quote by a Dutch man is taken ... Richenda Gambles entitled, "Work-Personal Life Harmonization: Visions and Pragmatic ...
Cached Biology Technology:aOva Technologies raises $3 million 2Wisconsin cities make progress on wireless Internet coverage 2Wisconsin cities make progress on wireless Internet coverage 3Wisconsin cities make progress on wireless Internet coverage 4Work-life imbalance - A global problem getting worse 2Work-life imbalance - A global problem getting worse 3Work-life imbalance - A global problem getting worse 4Work-life imbalance - A global problem getting worse 5
(Date:10/31/2014)... deer still live in Nuristan Province – some 60 ... deer scent glands are more valuable than gold , ... Oryx , NEW YORK (October 31, 2014) ... sighting, a strange deer with vampire-like fangs still persists ... to a research team led by the Wildlife Conservation ...
(Date:10/31/2014)... are letting the air out of a nagging mystery about ... long speculated as to why animal species didn,t flourish sooner, ... prosper at the end of the Proterozoic period, about 800 ... before that, when most researchers think there also was plenty ... great then, after all. , In a study published Oct. ...
(Date:10/31/2014)... in cities is good for attracting species, but it may ... University of Iowa study has found. , The researchers surveyed ... and recorded the abundance of two insects that interact with ... trees, black cherry and black walnut, they didn,t find a ... that feed on the walnuts and black cherries and a ...
Breaking Biology News(10 mins):Strange, fanged deer persists in Afghanistan 2Lack of oxygen delayed the rise of animals on Earth 2Green spaces don't ensure biodiversity in urban areas 2
... animals go through a period of torpor to conserve energy ... to energy-saving mode, the champion by far among vertebrates is ... for several years buried in the mud in the absence ... feat? A team of scientists at the University of Queensland ...
... A group of plant proteins that "shut the door" ... been identified for the first time by a team of ... at UC Berkeley. Findings from the study, which will ... of Science Biology , provide a better understanding of plants, ...
... Netherlands: The efficacy of preimplantation genetic screening (PGS) has ... reproduction over the past few years. None of the ... works or not. Now the European Society of Human,Reproduction ... to try to find out if a novel,method of ...
Cached Biology News:Super-sleepers could help super-sizers! 2Plant protein 'doorkeepers' block invading microbes, study finds 2Plant protein 'doorkeepers' block invading microbes, study finds 3ESHRE launches international study of polar body screening 2
Anti-Kusabira Orange Monoclonal Antibody Description: 100 g Research Focus: tag Storage: -20C Shipping Temperature: 4C...
alpha/beta-Tubulin Antibody Ship: Hot Store: -20 C...
Anti-Kusabira Orange Monoclonal Antibody Description: 100 g Research Focus: tag Storage: -20C Shipping Temperature: 4C...
Mouse monoclonal [CIG 3A11/5] to Cig2 (rating: *****) ( Abpromise for all tested applications)....
Biology Products: